Announcements and Notices - [Change in Auditors]

Everest Medicines Limited operates as a late clinical-stage biopharmaceutical company. The Company engages in licensing, clinical development, and commercialization of therapies for oncology, immunology, cardio-renal disease, and infectious disease. Everest Medicines markets its products in China and other emerging Asia Pacific markets.

Change Of Auditors

Announcements and Notices - [Other - Business Update]

Voluntary Announcement Business Update On Nefecon Development

Announcements and Notices - [Share Scheme]

Grant Of Options And Awards

Notification Letter And Reply Form To Non-Registered Shareholders - 2024 Interim Report And Arrangement Of Electronic Dissemination Of Corporate Communications

Notification Letter And Reply Form To Registered Shareholders - 2024 Interim Report And Arrangement Of Electronic Dissemination Of Corporate Communications

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00